Impact of an Integrated Obesity Management System on Patient's Care (ROGMF-2)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Marie-France Langlois, Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT00991640
First received: October 7, 2009
Last updated: March 3, 2014
Last verified: March 2014
  Purpose

The investigators developed a program aimed at enhancing primary care physician (PCP) teams' expertise, self-efficacy and attitudes with respect to obesity management. The investigators implemented and evaluated this obesity management system based on a preceptorship combined with a virtual learning community favouring continuous support of family medicine groups (FMGs, Groupes de Médecine Familiale) by a team of experts in obesity management; significant improvements regarding their attitudes and perception of self-efficacy were observed immediately after the preceptorship and maintained after one year. Furthermore, the investigators observed significant changes in their practice that were maintained one year later.

The investigators hypothesize that their program combining preceptorships with a virtual community will improve: (1) management and weight loss of obese/overweight subjects who are treated by PCPs for hypertension (HTN), type 2 diabetes (DM2) or impaired glucose tolerance (IGT); and (2) screening and initial management of obesity among unselected patients of PCPs who practice in FMGs.


Condition Intervention
Obesity
Behavioral: 2-day preceptorship on obesity management

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Health Services Research
Official Title: Impact of an Integrated Obesity Management System on Patient's Care

Resource links provided by NLM:


Further study details as provided by Université de Sherbrooke:

Primary Outcome Measures:
  • Among patients from the targeted diseases group, we aim at improving: a)the proportion of subjects who have an initial intervention planned, according to the CCPGO; b)the proportion of subjects who lose at least 5% of their initial weight. [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  • Among patients from the regular follow-up group, we aim at improving: a)the proportion of patients who have measured weight, BMI and waist circumference and b)the proportion of overweight or obese subjects who have an initial intervention planned. [ Time Frame: 18 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Among health professionals who receive the intervention (vs. those who did not), we aim at ameliorating their attitudes and perceptions towards patients and treatment effectiveness. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Among health professionals who receive the intervention (vs. those who did not), we aim at improving their perception of self-efficacy in managing obesity. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Among health professionals who receive the intervention (vs. those who did not), we aim at increasing their knowledge and expertise on obesity management and changing their practice. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Among patients who are followed by PCPs who receive the intervention (vs. no intervention), we aim at:a) evaluating their attitudes and perceptions regarding obesity/overweight and lifestyle and b)improving their satisfaction regarding their management. [ Time Frame: 18 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 460
Study Start Date: November 2009
Estimated Study Completion Date: June 2014
Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
No intervention
Experimental: Preceptorships
Preceptorships with e-learning
Behavioral: 2-day preceptorship on obesity management

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients who have, during the past 2 years, at least 4 documented visits for the targeted diseases group and at least 2 visits for the regular follow-up group

Exclusion Criteria:

  • Active mental health problem
  • Active psychiatric disorder
  • Cancer in the last five years
  • Patient with medication that changed in the last 6 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00991640

Locations
Canada, Quebec
Université de Sherbrooke
Sherbrooke, Quebec, Canada, J1H 5N4
Sponsors and Collaborators
Université de Sherbrooke
Canadian Institutes of Health Research (CIHR)
  More Information

No publications provided

Responsible Party: Marie-France Langlois, Pincipal investigator, Université de Sherbrooke
ClinicalTrials.gov Identifier: NCT00991640     History of Changes
Other Study ID Numbers: 09-022
Study First Received: October 7, 2009
Last Updated: March 3, 2014
Health Authority: Canada: Health Canada

Additional relevant MeSH terms:
Obesity
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on September 30, 2014